Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Yet to be rewarded
View:
Post by Thenorth1990 on Jun 07, 2021 2:59pm

Yet to be rewarded

The reaction to SP is quite Luke warm. However almost everything is I'm our favor. I personally feel we are bit late to the serology party, I believe slowly and steadily over the next few months we will reach around .50 cents even without serology test . Atleast we have one less thing to Google lol
Comment by tamarindo1 on Jun 07, 2021 3:09pm
I don.t know if this has already been posted. https://www.bbc.com/news/health-57383763
Comment by farmerjane on Jun 07, 2021 4:08pm
Look at Biogen up $109 to $395
Comment by M101 on Jun 07, 2021 4:19pm
I want to buy an ETF for the ROI on regultory capture, it's got a 10 year average over 10,000% 
Comment by retiredcop on Jun 07, 2021 4:25pm
Actually i dsagree that we are late on the serology party..the need for the antibody immunity test is even more important now that people are vaccinated and now govt and vaccine producers are trying to figure out how long will any protection last...this is all  just starting up...most of whats happening with PMN S serology test is limited to very few people...and I hope we have figured this ...more  
Comment by Thenorth1990 on Jun 07, 2021 4:39pm
I am not denying the need for serology test. But just that o many companies are already out there, so not sure hiw much we business ee can capture. And I agree what we have is quite limited info. Again I will be happy if are able to generate enough to fund the trials. I hope today's news might open up more scope for partnership / funding
Comment by Annayya on Jun 07, 2021 4:25pm
I agree. We went up 30% which is not bad but I was expecting see 30s today. Anyway, we had 7.8 million in volume today which is the highest for the year. Let's hope the management has some good news to follow up this week.
Comment by M101 on Jun 07, 2021 5:03pm
It's a sector play, PMN has no business outperforming the sector leader on day 1. I just hope Elliot didn't wet himself when someone finally returned a call today. 
Comment by WsrThanWenYungr on Jun 07, 2021 7:37pm
Yet another serology test is like nothing compared to a cure for Alzheimer's. Not only is PMN a good opportunity to help fund your retiremnt, it's an opportunity to actualy remember it.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities